清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis

医学 恶性胸腔积液 胸膜成形术 内科学 荟萃分析 胸腔积液 中医药 随机对照试验 肿瘤科 病理 替代医学
作者
Cheng-Qiong Wang,Jiao Xu,Hong Jiang,Xiao-Tian Zheng,Yan Zhang,Xiao-Rong Huang,Fei She,Teng-Yang Fan,Lin Zhan,Jihong Feng,Qihai Gong,Xue Xiao,Xiaofan Chen,Zheng Xiao
出处
期刊:Phytomedicine [Elsevier]
卷期号:115: 154847-154847 被引量:5
标识
DOI:10.1016/j.phymed.2023.154847
摘要

Aidi injection (Aidi), a traditional Chinese medicine injection, is often practiced to control malignant pleural effusion (MPE). We performed a registered systematic review and meta-analysis (PROSPERO: CRD42022337611) to clarify the clinical role of Aidi in MPE, reveal optimal combinations of Aidi and chemical agents, their indications, therapeutic route and usage, and demonstrate their clinical effectiveness and safety. All randomized controlled trials (RCTs) about Aidi in controlling MPE were collected from Chinese and English databases (up to October 2022). We clustered them into multiple homogenous regimens, evaluated the risk-of-bias at outcome level using a RoB 2, extracted and pooled the data using meta-analysis or descriptive analysis, and finally summarized their evidence quality. All 56 studies were clustered into intrapleural administration with Aidi alone or plus chemical agents, and intravenous administration with Aidi for MPE. Intrapleural administration with Aidi alone displayed similar clinical responses on Cisplatin (DDP) alone. Only administration with Aidi plus DDP significantly improved complete response and quality of life, and displayed a low pleurodesis failure, disease progression, hematotoxicity, gastrointestinal and hepatorenal toxicity. For patients with moderate to massive effusion, Karnofsky Performance Status score ≥ 50 or anticipated survival time ≥3 months, Aidi (50 ml to 80 ml each time, one time each week and three to eight times) plus DDP (20 to 30 mg, 40 to 50 mg, or 60 to 80 mg each time) significantly improved clinical responses. Most results had moderate to low quality. Current evidences indicate that Aidi, a pleurodesis agent, plays an interesting clinical role in controlling MPE. Aidi plus DDP perfusion is a most commonly used regimen, which shows a significant improvement in clinical responses. These findings also provide an indication and possible optimal usage for rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
xun发布了新的文献求助10
7秒前
shhoing应助科研通管家采纳,获得10
48秒前
科研通AI2S应助科研通管家采纳,获得10
48秒前
shhoing应助科研通管家采纳,获得10
48秒前
xun完成签到,获得积分20
57秒前
黄天完成签到 ,获得积分10
1分钟前
乐乐应助紫津采纳,获得10
2分钟前
酷酷海豚完成签到,获得积分10
2分钟前
紫津完成签到,获得积分10
2分钟前
shhoing应助科研通管家采纳,获得10
2分钟前
852应助科研通管家采纳,获得10
2分钟前
shhoing应助科研通管家采纳,获得40
2分钟前
隐形曼青应助科研通管家采纳,获得10
2分钟前
3分钟前
健忘的溪灵完成签到 ,获得积分10
3分钟前
大医仁心完成签到 ,获得积分10
4分钟前
科研通AI6应助岚月采纳,获得30
5分钟前
两个榴莲完成签到,获得积分0
5分钟前
5分钟前
科研通AI2S应助科研通管家采纳,获得10
6分钟前
shhoing应助科研通管家采纳,获得10
6分钟前
科研通AI2S应助科研通管家采纳,获得30
6分钟前
岚月发布了新的文献求助30
6分钟前
岚月完成签到,获得积分10
7分钟前
糊涂的青烟完成签到 ,获得积分10
7分钟前
激动的似狮完成签到,获得积分10
8分钟前
shhoing应助科研通管家采纳,获得10
8分钟前
科研通AI2S应助科研通管家采纳,获得10
8分钟前
科研通AI2S应助科研通管家采纳,获得10
8分钟前
感动初蓝完成签到 ,获得积分10
9分钟前
tt完成签到,获得积分10
9分钟前
大鸟依人发布了新的文献求助10
10分钟前
科研通AI2S应助科研通管家采纳,获得10
10分钟前
shhoing应助科研通管家采纳,获得10
10分钟前
科研通AI2S应助科研通管家采纳,获得10
10分钟前
orixero应助大鸟依人采纳,获得10
11分钟前
cao_bq完成签到,获得积分10
11分钟前
积雪完成签到 ,获得积分10
12分钟前
yang完成签到 ,获得积分10
12分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1621
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 800
King Tyrant 600
A Guide to Genetic Counseling, 3rd Edition 500
Laryngeal Mask Anesthesia: Principles and Practice. 2nd ed 500
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5561563
求助须知:如何正确求助?哪些是违规求助? 4646662
关于积分的说明 14678727
捐赠科研通 4587989
什么是DOI,文献DOI怎么找? 2517261
邀请新用户注册赠送积分活动 1490549
关于科研通互助平台的介绍 1461566